Purine antimetabolite drug used to treat acute lymphocytic leukemia, Crohns disease, ulcerative colitis, and inflammatory bowel disease.1 It inhibits DNA synthesis by inhibiting the production of purine containing nucleotides. The immunomodulatory activity of 6-Mercaptopurine is mainly the result of the 6-MP metabolite 6-thioguanine triphosphate (6-TGTP) binding to small GTPase Rac1.2
* VAT and and shipping costs not included. Errors and price changes excepted